Epidemiology of haemodialysis outcomes

AK Bello, IG Okpechi, MA Osman, Y Cho… - Nature Reviews …, 2022 - nature.com
Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …

The current and future landscape of dialysis

J Himmelfarb, R Vanholder, R Mehrotra… - Nature Reviews …, 2020 - nature.com
The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set
in motion several dramatic changes in the epidemiology, economics and ethical frameworks …

[HTML][HTML] Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) …

R Mehrotra, SN Davison, K Farrington, JE Flythe… - Kidney international, 2023 - Elsevier
Individuals with kidney failure undergoing maintenance dialysis frequently report a high
symptom burden that can interfere with functioning and diminish life satisfaction. Until …

Symptom prioritization among adults receiving in-center hemodialysis: a mixed methods study

JE Flythe, T Hilliard, G Castillo, K Ikeler… - Clinical Journal of the …, 2018 - journals.lww.com
Results There were 32 participants across three focus groups and 87 survey respondents
from 27 states in the United States. The physical symptoms of insomnia, fatigue, muscle …

Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial

R Mehrotra, D Cukor, M Unruh, T Rue… - Annals of internal …, 2019 - acpjournals.org
Background: Although depression is common among patients receiving maintenance
hemodialysis, data on their acceptance of treatment and on the comparative efficacy of …

Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial

SS Hedayati, LP Gregg, T Carmody, N Jain, M Toups… - Jama, 2017 - jamanetwork.com
Importance Major depressive disorder (MDD) is prevalent among patients with chronic
kidney disease (CKD) and is associated with morbidity and mortality. The efficacy and …

Psychotropic drugs and adverse kidney effects: a systematic review of the past decade of research

JJ Damba, K Bodenstein, P Lavin, J Drury, H Sekhon… - CNS drugs, 2022 - Springer
Abstract Background and Objective Psychotropic drugs are a heterogenous group of
treatments prescribed for many psychiatric disorders, often for long periods. Their effects on …

Pharmacologic and psychological interventions for depression treatment in patients with kidney disease

LP Gregg, SS Hedayati - Current opinion in nephrology and …, 2020 - journals.lww.com
Although the data do not support unlimited use of SSRIs in patients with CKD or end-stage
kidney disease, it is reasonable to initiate a cautious trial of sertraline while closely …

Comparative cardiac safety of selective serotonin reuptake inhibitors among individuals receiving maintenance hemodialysis

MM Assimon, MA Brookhart… - Journal of the American …, 2019 - journals.lww.com
Background Individuals receiving maintenance hemodialysis may be particularly
susceptible to the lethal cardiac consequences of drug-induced QT prolongation because …

Depression in dialysis

N Tian, N Chen, PKT Li - Current Opinion in Nephrology and …, 2021 - journals.lww.com
Depression management through early screening and continuous care models emphasizing
dynamic relationships between healthcare teams, patients and families should be …